The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations
Open accessAbstract
National attention continues to focus on the need to improve care for individuals with co-occurring mental illnesses and substance use disorders, as emphasized in the 2003 President's New Freedom Commission Report on Mental Health and recent publications from the Substance Abuse and Mental Health Services Administration (SAMHSA). These reports document the need for best practice recommendations that can be translated into routine clinical care. Although efforts are underway to synthesize literature in this area, few focused recommendations are available that include expert opinion and evidence-based findings on the management of specific co-occurring disorders, such as schizophrenia and addiction. In response to the need for user-friendly recommendations on the treatment of schizophrenia and addiction, a consensus conference of experts from academic institutions and state mental health systems was organized to 1) frame the problem from clinical and systems-level perspectives; 2) identify effective and problematic psychosocial, pharmacological, and systems practices; and 3) develop a summary publication with recommendations for improving current practice. The results of the consensus meeting served as the foundation for this publication, which presents a broad set of recommendations for clinicians who treat individuals with schizophrenia. "Integrated treatment" is the new standard for evidence-based treatment for this population and recommendations are given to help clinicians implement such integrated treatment. Specific recommendations are provided concerning screening for substance use disorders in patients with schizophrenia, assessing motivation for change, managing medical conditions that commonly occur in patients with dual diagnoses (e.g., cardiovascular disease, liver complications, lung cancer, HIV, and hepatitis B or C infections) and selecting the most appropriate medications for such patients to maximize safety and minimize drug interactions, use of evidence-based psychosocial interventions for patients with dual diagnoses (e.g., Dual Recovery Therapy, modified cognitive-behavioral therapy, modified motivational enhancement therapy, and the Substance Abuse Management Module), and key pharmacotherapy principles for treating schizophrenia, substance use disorders, and comorbid anxiety, depression, and sleep problems in this population. Finally the article reviews programmatic and systemic changes needed to overcome treatment barriers and promote the best outcomes for this patient population. An algorithm summarizing the consensus recommendations is provided in an appendix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
In search of how people change: Applications to addictive behaviors.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992) · American Psychologist · doi:10.1037/0003-066x.47.9.1102 · Cited by 8,596
Skinner, H. A. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90005-3 · Cited by 3,134
Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.1 · Cited by 1,428
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.31 · Cited by 589
Incidence of Cancer Among Persons With Schizophrenia and Their Relatives
Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., & Lönnqvist, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.573 · Cited by 292
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073920 · Cited by 191
Quetiapine in bipolar disorder and cocaine dependence
Brown, E. S., Nejtek, V. A., Perantie, D. C., & Bobadilla, L. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.02229.x · Cited by 122
Psychopathology in dual diagnosis and non-addicted schizophrenics—are there differences
Soyka, M., Albus, M., Immler, B., Kathmann, N., & Hippius, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170032 · Cited by 58
Research works printed but not linked: 99
- Regier, 1990, JAMA, 264, 2511, 10.1001/jama.1990.03450190043026 · DOI · Paper page
- de Leon, 1996, Schizophr Bull, 22, 405, 10.1093/schbul/22.3.405 · DOI
- Ziedonis, 2004, CNS Spectrums, 9, 892, 10.1017/S1092852900009718 · DOI
- Sacks, 1997, Subst Use Misuse, 32, 1217, 10.3109/10826089709035472 · DOI
- Caton, 1994, Am J Pub Health, 84, 265, 10.2105/AJPH.84.2.265 · DOI · Paper page
- Cuffel, 1994, J Nerv Ment Disease, 182, 704, 10.1097/00005053-199412000-00005 · DOI
- Haywood, 1995, Am J Psychiatry, 152, 856, 10.1176/ajp.152.6.856 · DOI · Paper page
- Serper, 1995, Am J Psychiatry, 152, 1464, 10.1176/ajp.152.10.1464 · DOI
- Smelson, 2002, J Nerv Ment Dis, 190, 200, 10.1097/00005053-200203000-00010 · DOI
- Drake, 2001, Psychiatr Serv, 52, 469, 10.1176/appi.ps.52.4.469 · DOI · Paper page
- Bellack, 1999, Psychiatr Serv, 50, 75, 10.1176/ps.50.1.75 · DOI
- Carey, 1997, Psychol Addict Behav, 11, 26, 10.1037/0893-164X.11.1.26 · DOI · Paper page
- Rosenthal, 1992, Am J Addict, 1, 339
- Shaner, 2003, Psychiatr Serv, 54, 1287, 10.1176/appi.ps.54.9.1287 · DOI
- Ziedonis, 1994, Hosp Community Psychiatry, 45, 204
- Teitelbaum, 1997, The Behavior Therapist, 20, 19
- Skinner, 1982, J Stud Alcohol, 43, 1157, 10.15288/jsa.1982.43.1157 · DOI · Paper page
- Rosenberg, 1998, Am J Psychiatry, 155, 232, 10.1176/ajp.155.2.232 · DOI · Paper page
- Carey, 1998, Addict Behav, 23, 735, 10.1016/S0306-4603(98)00063-X · DOI
- Bartels, 1993, J Nerv Ment Dis, 181, 227, 10.1097/00005053-199304000-00003 · DOI · Paper page
- Mueser, 1992, J Consult Clin Psychol, 60, 845, 10.1037/0022-006X.60.6.845 · DOI · Paper page
- Ziedonis, 1996, Dir Psychiatry, 16, 1
- Allen, 2001, J Subst Abuse Treat, 20, 81, 10.1016/S0740-5472(00)00144-6 · DOI
- Ziedonis, 1997, Schizophr Bull, 23, 229, 10.1093/schbul/23.2.229 · DOI · Paper page
- Ries, 1990, Hosp Community Psychiatry, 41, 1230
- Mukamal, 2004, Am J Geriatr Cardiol, 13, 22, 10.1111/j.1076-7460.2004.01334.x · DOI
- Dalton, 2004, Am J Psychiatry, 161, 903, 10.1176/appi.ajp.161.5.903 · DOI
- Davidson, 2001, Aust N Z J Psychiatry, 35, 196, 10.1046/j.1440-1614.2001.00877.x · DOI · Paper page
- Allison, 1999, J Clin Psychiatry, 60, 215, 10.4088/JCP.v60n0402 · DOI · Paper page
- Dixon, 1999, J Nerv Ment Dis, 187, 496, 10.1097/00005053-199908000-00006 · DOI · Paper page
- Herran, 2000, Schizophr Res, 41, 373, 10.1016/S0920-9964(99)00082-1 · DOI
- McElroy, 2004, J Clin Psychiatry, 65, 634, 10.4088/JCP.v65n0507 · DOI · Paper page
- Marder, 2004, Am J Psychiatry, 161, 1334, 10.1176/appi.ajp.161.8.1334 · DOI · Paper page
- McCance, 1995, Pharmacol Exp Ther, 274, 215
- McCance-Katz, 1998, Biol Psychiatry, 44, 250, 10.1016/S0006-3223(97)00426-5 · DOI · Paper page
- Flegal, 1985, Recent Dev Alcohol, 3, 165, 10.1007/978-1-4615-7715-7_13 · DOI
- Kuo, 2004, Drug Alcohol Depend, 73, 69, 10.1016/j.drugalcdep.2003.10.007 · DOI
- Kellerman, 2003, J Infect Dis, 188, 571, 10.1086/377135 · DOI · Paper page
- Butterfield, 2003, Psychiatr Serv, 54, 848, 10.1176/appi.ps.54.6.848 · DOI
- Stoskopf, 2001, Community Ment Health J, 37, 469, 10.1023/A:1017577827658 · DOI
- Fernandez, 1991, Psychiatr Med, 9, 377
- Batki, 1990, West J Med, 152, 547
- Bagchi, 2004, Schizophr Res, 71, 435, 10.1016/j.schres.2004.02.021 · DOI
- Ziedonis, 2001, Psychiatr Ann, 31, 255, 10.3928/0048-5713-20010401-09 · DOI
- Carey, 1996, Community Ment Health J, 32, 291, 10.1007/BF02249430 · DOI · Paper page
- Bartels, 1996, J Nerv Ment Dis, 184, 379, 10.1097/00005053-199606000-00011 · DOI
- Blankertz, 1993, J Ment Health Adm, 20, 100, 10.1007/BF02519235 · doi:10.1007/bf02519235
- Hanson, 1990, J Subst Abuse Treat, 7, 109, 10.1016/0740-5472(90)90006-C · doi:10.1016/0740-5472(90)90006-c
- Hellerstein, 1995, Am J Addict, 4, 33, 10.1111/j.1521-0391.1995.tb00256.x · doi:10.1111/j.1521-0391.1995.tb00256.x
- Rahav, 1995, J Psychoactive Drugs, 27, 93, 10.1080/02791072.1995.10471677 · DOI
- Burnam, 1995, J Addict Dis, 14, 111, 10.1300/J069v14n04_07 · DOI
- Bennett, 2001, J Subst Abuse Treat, 20, 163, 10.1016/S0740-5472(00)00167-7 · DOI
- Mueser, 1998, Schizophr Bull, 24, 37, 10.1093/oxfordjournals.schbul.a033314 · DOI · Paper page
- Johnson, 1999, J Psychiatr Ment Health Nurs, 6, 445, 10.1046/j.1365-2850.1999.00252.x · doi:10.1046/j.1365-2850.1999.00252.x
- Schaedle, 2002, Psychiatr Serv, 53, 207, 10.1176/appi.ps.53.2.207 · DOI
- Rosenheck, 2001, Arch Gen Psychiatry, 58, 1073, 10.1001/archpsyc.58.11.1073 · DOI
- Okin, 2000, Am J Emerg Med, 18, 603, 10.1053/ajem.2000.9292 · DOI · Paper page
- Witbeck, 2000, J Subst Abuse Treat, 9, 39, 10.1016/S0740-5472(99)00090-2 · DOI
- Smelson, 2005, Journal of Dual Diagnosis, 1, 47, 10.1300/J374v01n03_05 · DOI
- Weiss, 1998, J Clin Psychiatry, 59, 172, 10.4088/JCP.v59n0405 · DOI
- Rychtarik, 2000, J Stud Alcohol, 61, 134, 10.15288/jsa.2000.61.134 · DOI
- Farren, 2000, Drug Alcohol Depend, 59, 153, 10.1016/S0376-8716(99)00114-3 · DOI
- Zevin, 1999, Clin Pharmacokinet, 36, 425, 10.2165/00003088-199936060-00004 · DOI · Paper page
- Desai, 2001, CNS Drugs, 15, 469, 10.2165/00023210-200115060-00005 · DOI · Paper page
- Bozikas, 2004, Eur Neuropsychopharmacol, 14, 39, 10.1016/S0924-977X(03)00061-0 · DOI
- McEvoy, 1999, J Clin Psychiatry, 60, 1
- Kane, 2003, J Clin Psychiatry, 64, 1
- Miller, 2004, J Clin Psychiatry, 65, 500, 10.4088/JCP.v65n0408 · DOI · Paper page
- Albanese, 1994, Am J Psychiatry, 151, 780
- Marcus, 1995, Am J Psychiatry, 152, 959
- Buckley, 1998, J Subst Abuse Treat, 15, 113, 10.1016/S0740-5472(97)00134-7 · DOI
- Tsuang, 1999, Am J Psychiatry, 156, 1119, 10.1176/ajp.156.7.1119a · DOI
- Tsuang, 2002, J Clin Psychopharmacol, 22, 629, 10.1097/00004714-200212000-00017 · DOI
- Buckley, 1994, Am J Psychiatry, 151, 385, 10.1176/ajp.151.3.385 · DOI
- Conley, 1998, Schizophr Res, 33, 95, 10.1016/S0920-9964(98)00062-0 · DOI
- Lee, 1998, Can J Psychiatry, 43, 855, 10.1177/070674379804300705 · DOI
- Drake, 2000, Schizophr Bull, 26, 441, 10.1093/oxfordjournals.schbul.a033464 · DOI · Paper page
- Zimmet, 2000, J Clin Psychopharmacol, 20, 94, 10.1097/00004714-200002000-00016 · DOI · Paper page
- Littrell, 2001, J Subst Abuse Treat, 21, 217, 10.1016/S0740-5472(01)00205-7 · DOI
- Smelson, 2002, Can J Psychiatry, 47, 671, 10.1177/070674370204700710 · DOI
- Poling, 2005, Addictive Disorders Their Treatment, 4, 1, 10.1097/00132576-200503000-00001 · DOI
- Levin, 1998, Am J Drug Alcohol Abuse, 24, 343, 10.3109/00952999809016902 · DOI
- Green, 2003, Schizophr Res, 60, 81, 10.1016/S0920-9964(02)00231-1 · DOI
- Smelson, 2003, Schizophr Res, 60, 303, 10.1016/S0920-9964(03)80226-8 · doi:10.1016/s0920-9964(03)80226-8
- Carol, 2001, Psychiatr Serv, 52, 1029, 10.1176/appi.ps.52.8.1029 · doi:10.1176/appi.ps.52.8.1029
- Smelson, 2002, Psychiatr Serv, 53, 1612, 10.1176/appi.ps.53.12.1612 · DOI
- George, 2000, Am J Psychiatry, 157, 1835, 10.1176/appi.ajp.157.11.1835 · DOI · Paper page
- Petrakis, 2004, Psychopharmacology (Berl), 172, 291, 10.1007/s00213-003-1658-9 · DOI
- Farren, 2002, Am J Addict, 11, 228, 10.1080/10550490290088009 · DOI
- Zimmet, 2000, J Clin Psychopharmacol, 20, 94, 10.1097/00004714-200002000-00016 · DOI · Paper page
- George, 2002, Biol Psychiatry, 52, 53, 10.1016/S0006-3223(02)01339-2 · DOI · Paper page
- Weiner, 2001, Am J Psychiatry, 158, 635, 10.1176/appi.ajp.158.4.635 · DOI
- Ziedonis, 1997, Schizophr Bull, 23, 247, 10.1093/schbul/23.2.247 · DOI · Paper page
- Williams, 2004, Addict Behav, 29, 1067, 10.1016/j.addbeh.2004.03.009 · DOI · Paper page
- Williams, 2004, Psychiatr Serv, 55, 1064, 10.1176/appi.ps.55.9.1064 · DOI
- DeQuardo, 1994, Psychiatr Res, 28, 267, 10.1016/0022-3956(94)90010-8 · DOI
- Negrete, 1986, Psychol Med, 16, 515, 10.1017/S0033291700010278 · DOI · Paper page
- Raphael, 2005, J Psychiatr Pract, 11, 161, 10.1097/00131746-200505000-00004 · DOI
- Ries, 1993, J Addict Dis, 12, 103, 10.1300/J069v12n03_09 · DOI
Cited by
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Self-citationDrake, R. E., O'Neal, E. L., & Wallach, M. A. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.01.011 · Cited by 447
Psychosocial Treatments for Schizophrenia
Mueser, K. T., Deavers, F., Penn, D. L., & Cassisi, J. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185620 · Cited by 402
Treatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 284
Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse
Hunt, G. E., Siegfried, N., Morley, K., Sitharthan, T., & Cleary, M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt160 · Cited by 266
Metadata
- Authors
- ZIEDONIS, D. M., SMELSON, D., ROSENTHAL, R. N., BATKI, S. L., GREEN, A. I., HENRY, R. J., MONTOYA, I., PARKS, J., & WEISS, R. D.
- Venue
- Journal of Psychiatric Practice
- Published
- 2005-09
- Volume
- 11
- Issue
- 5
- Pages
- 315-339
- ISSN
- 1527-4160 (ISSN-L)
- 1538-1145
- OpenAlex
- W1971540569
- Cited by
- 195
- References
- 9
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations. https://app.cochat.ai/papers/10.1097/00131746-200509000-00005
- The paper
- ZIEDONIS, D. M., SMELSON, D., ROSENTHAL, R. N., BATKI, S. L., GREEN, A. I., HENRY, R. J., MONTOYA, I., PARKS, J., & WEISS, R. D. (2005). Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations. Journal of Psychiatric Practice. https://doi.org/10.1097/00131746-200509000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.